Astria Therapeutics, Inc. enterprise value

The Enterprise Value as of October 2026 (TTM) for Astria Therapeutics, Inc. (ATXS) is 626.31M

According to Astria Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 626.31M. This represents a change of 95.68% compared to the average of 320.07M of the last 4 quarters.

Astria Therapeutics, Inc. (ATXS) Historical Enterprise Value (quarterly & annually)

How has ATXS Enterprise Value performed in the past?

The mean historical Enterprise Value of Astria Therapeutics, Inc. over the last ten years is 81.36M. The current 626.31M Enterprise Value has changed 669.77% with respect to the historical average. Over the past ten years (40 quarters), ATXS's Enterprise Value was at its highest in in the September 2024 quarter at 546.65M. The Enterprise Value was at its lowest in in the March 2021 quarter at -81481297.14.

Astria Therapeutics, Inc. (ATXS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Astria Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Astria Therapeutics, Inc. (ATXS) Average Enterprise Value

How has ATXS Enterprise Value performed in the past?

The current Enterprise Value of Astria Therapeutics, Inc. (ATXS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Astria Therapeutics, Inc. (ATXS) Enterprise Value vs. Peers

How is ATXS’s Enterprise Value compared to its peers?

Astria Therapeutics, Inc.’s Enterprise Value is less than Erasca, Inc. (4.96B), less than MeiraGTx Holdings plc (868.12M), greater than ArriVent BioPharma, Inc. (529.07M), less than MBX Biosciences, Inc. Common Stock (2.57B), greater than Valneva SE (539.69M), less than Ginkgo Bioworks Holdings, Inc. (979.52M), less than Iovance Biotherapeutics, Inc. (3.55B), greater than Arvinas, Inc. (398.89M), less than Replimune Group, Inc. (1.56B), less than Day One Biopharmaceuticals, Inc. (2.03B),

Build a custom stock screener for Astria Therapeutics, Inc. (ATXS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Astria Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Astria Therapeutics, Inc. (ATXS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Astria Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.